RNU7-121P

Across TCGA pan-cancer cohorts, RNU7-121P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-121P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-121P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-121P expression acts as an unfavorable survival marker.

BLCA, GBM, and LAML are the cancer types where RNU7-121P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.062	0.720	<.001	72	view →
GBM	OS	Tertile	All	0.116	0.417	<.001	54	view →
LAML	DFS	Tertile	All	0.082	0.582	.004	36	view →
LGG	DFS	Tertile	All	0.564	0.832	.005	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-121P–BLCA (OS)

Open the BLCA breakdown →